Dose subjects but not using them [Two-Stage / GS Designs]

posted by d_labes  – Berlin, Germany, 2015-09-22 15:49 (3132 d 01:37 ago) – Posting: # 15445
Views: 4,621

Dear Kotu,

sounds to me in contrast to our Capt'n like something similar to 'spare' subjects.

The EMA guidance states in this respect:
"The data from all treated subjects should be treated equally. It is not acceptable to have a protocol which specifies that ‘spare’ subjects will be included in the analysis only if needed as replacements for other subjects who have been excluded. It should be planned that all treated subjects should be included in the analysis, even if there are no drop-outs."

Moreover it is IMHO highly unethical to expose subjects to the API and taking blood samples from them for nothing (not to use their data).

Regards,

Detlew

Complete thread:

UA Flag
Activity
 Admin contact
22,987 posts in 4,824 threads, 1,665 registered users;
87 visitors (0 registered, 87 guests [including 5 identified bots]).
Forum time: 17:26 CEST (Europe/Vienna)

The only way to comprehend what mathematicians mean by Infinity
is to contemplate the extent of human stupidity.    Voltaire

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5